Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs

Plus, news about Henlius, Sandoz, Cellectar Biosciences, Ono Pharma and Altamira Therapeutics: Immunic’s Phase 2 multiple sclerosis readout: The company said vidofludimus calcium (IMU-838) reduced the relative risk of disease worsening ...